Found 63 hits of Enzyme Inhibition Constant Data Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM15234
((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)Show SMILES [H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)c2occ3c2[C@]1(C)[C@@H](COC)OC3=O |r,c:15| Show InChI InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM15234
((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)Show SMILES [H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)c2occ3c2[C@]1(C)[C@@H](COC)OC3=O |r,c:15| Show InChI InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM15234
((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)Show SMILES [H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)c2occ3c2[C@]1(C)[C@@H](COC)OC3=O |r,c:15| Show InChI InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM15234
((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)Show SMILES [H][C@@]12CCC(=O)[C@@]1(C)C[C@@H](OC(C)=O)C1=C2C(=O)c2occ3c2[C@]1(C)[C@@H](COC)OC3=O |r,c:15| Show InChI InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem
Patents
Similars
| DrugBank PDB Article PubMed
| n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333219
(6-(6-methoxypyridin-3-yl)benzo[d]thiazol-2-amine |...)Show InChI InChI=1S/C13H11N3OS/c1-17-12-5-3-9(7-15-12)8-2-4-10-11(6-8)18-13(14)16-10/h2-7H,1H3,(H2,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333219
(6-(6-methoxypyridin-3-yl)benzo[d]thiazol-2-amine |...)Show InChI InChI=1S/C13H11N3OS/c1-17-12-5-3-9(7-15-12)8-2-4-10-11(6-8)18-13(14)16-10/h2-7H,1H3,(H2,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333220
(5-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-7-9(1-2-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333220
(5-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-7-9(1-2-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333215
(7-morpholinoquinazolin-4(3H)-one | CHEMBL1645100)Show InChI InChI=1S/C12H13N3O2/c16-12-10-2-1-9(7-11(10)13-8-14-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2,(H,13,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333215
(7-morpholinoquinazolin-4(3H)-one | CHEMBL1645100)Show InChI InChI=1S/C12H13N3O2/c16-12-10-2-1-9(7-11(10)13-8-14-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2,(H,13,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333222
(3-(2-aminobenzo[d]thiazol-6-yl)phenol | CHEMBL1645...)Show InChI InChI=1S/C13H10N2OS/c14-13-15-11-5-4-9(7-12(11)17-13)8-2-1-3-10(16)6-8/h1-7,16H,(H2,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333226
(4-(5-(thiophen-2-ylmethyl)-1,2,4-oxadiazol-3-yl)-1...)Show InChI InChI=1S/C9H7N5O2S/c10-8-7(12-16-13-8)9-11-6(15-14-9)4-5-2-1-3-17-5/h1-3H,4H2,(H2,10,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333221
(6-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-2-1-9(7-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333221
(6-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-2-1-9(7-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333222
(3-(2-aminobenzo[d]thiazol-6-yl)phenol | CHEMBL1645...)Show InChI InChI=1S/C13H10N2OS/c14-13-15-11-5-4-9(7-12(11)17-13)8-2-1-3-10(16)6-8/h1-7,16H,(H2,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 9.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333221
(6-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-2-1-9(7-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 9.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333220
(5-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-7-9(1-2-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.02E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333222
(3-(2-aminobenzo[d]thiazol-6-yl)phenol | CHEMBL1645...)Show InChI InChI=1S/C13H10N2OS/c14-13-15-11-5-4-9(7-12(11)17-13)8-2-1-3-10(16)6-8/h1-7,16H,(H2,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.08E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333211
(2-(pyridin-4-yl)thiazolo[5,4-d]pyrimidin-7-amine |...)Show InChI InChI=1S/C10H7N5S/c11-8-7-10(14-5-13-8)16-9(15-7)6-1-3-12-4-2-6/h1-5H,(H2,11,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.11E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333216
(4-(1H-pyrazolo[3,4-b]pyridin-4-yl)morpholine | CHE...)Show InChI InChI=1S/C10H12N4O/c1-2-11-10-8(7-12-13-10)9(1)14-3-5-15-6-4-14/h1-2,7H,3-6H2,(H,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333222
(3-(2-aminobenzo[d]thiazol-6-yl)phenol | CHEMBL1645...)Show InChI InChI=1S/C13H10N2OS/c14-13-15-11-5-4-9(7-12(11)17-13)8-2-1-3-10(16)6-8/h1-7,16H,(H2,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333221
(6-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-2-1-9(7-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333226
(4-(5-(thiophen-2-ylmethyl)-1,2,4-oxadiazol-3-yl)-1...)Show InChI InChI=1S/C9H7N5O2S/c10-8-7(12-16-13-8)9-11-6(15-14-9)4-5-2-1-3-17-5/h1-3H,4H2,(H2,10,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.42E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333215
(7-morpholinoquinazolin-4(3H)-one | CHEMBL1645100)Show InChI InChI=1S/C12H13N3O2/c16-12-10-2-1-9(7-11(10)13-8-14-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2,(H,13,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.42E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333216
(4-(1H-pyrazolo[3,4-b]pyridin-4-yl)morpholine | CHE...)Show InChI InChI=1S/C10H12N4O/c1-2-11-10-8(7-12-13-10)9(1)14-3-5-15-6-4-14/h1-2,7H,3-6H2,(H,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333210
(5-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | CHEMB...)Show InChI InChI=1S/C12H9N3/c1-4-13-5-2-9(1)11-7-10-3-6-14-12(10)15-8-11/h1-8H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333211
(2-(pyridin-4-yl)thiazolo[5,4-d]pyrimidin-7-amine |...)Show InChI InChI=1S/C10H7N5S/c11-8-7-10(14-5-13-8)16-9(15-7)6-1-3-12-4-2-6/h1-5H,(H2,11,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333217
(4-methyl-2-morpholinothiazole-5-carboxylic acid | ...)Show InChI InChI=1S/C9H12N2O3S/c1-6-7(8(12)13)15-9(10-6)11-2-4-14-5-3-11/h2-5H2,1H3,(H,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333217
(4-methyl-2-morpholinothiazole-5-carboxylic acid | ...)Show InChI InChI=1S/C9H12N2O3S/c1-6-7(8(12)13)15-9(10-6)11-2-4-14-5-3-11/h2-5H2,1H3,(H,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50024966
(6-Oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile...)Show InChI InChI=1S/C11H7N3O/c12-6-9-5-10(7-14-11(9)15)8-1-3-13-4-2-8/h1-5,7H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333211
(2-(pyridin-4-yl)thiazolo[5,4-d]pyrimidin-7-amine |...)Show InChI InChI=1S/C10H7N5S/c11-8-7-10(14-5-13-8)16-9(15-7)6-1-3-12-4-2-6/h1-5H,(H2,11,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50024966
(6-Oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile...)Show InChI InChI=1S/C11H7N3O/c12-6-9-5-10(7-14-11(9)15)8-1-3-13-4-2-8/h1-5,7H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333217
(4-methyl-2-morpholinothiazole-5-carboxylic acid | ...)Show InChI InChI=1S/C9H12N2O3S/c1-6-7(8(12)13)15-9(10-6)11-2-4-14-5-3-11/h2-5H2,1H3,(H,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333216
(4-(1H-pyrazolo[3,4-b]pyridin-4-yl)morpholine | CHE...)Show InChI InChI=1S/C10H12N4O/c1-2-11-10-8(7-12-13-10)9(1)14-3-5-15-6-4-14/h1-2,7H,3-6H2,(H,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.93E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333218
(7-morpholinopyrimido[4,5-d]pyrimidin-4-amine | CHE...)Show InChI InChI=1S/C10H12N6O/c11-8-7-5-12-10(15-9(7)14-6-13-8)16-1-3-17-4-2-16/h5-6H,1-4H2,(H2,11,12,13,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333212
(2-(pyridin-4-yl)benzo[d]oxazol-5-ol | CHEMBL164509...)Show InChI InChI=1S/C12H8N2O2/c15-9-1-2-11-10(7-9)14-12(16-11)8-3-5-13-6-4-8/h1-7,15H | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333224
(2-(dimethylamino)-6-morpholinopyrimidin-4(3H)-one ...)Show InChI InChI=1S/C10H16N4O2/c1-13(2)10-11-8(7-9(15)12-10)14-3-5-16-6-4-14/h7H,3-6H2,1-2H3,(H,11,12,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333218
(7-morpholinopyrimido[4,5-d]pyrimidin-4-amine | CHE...)Show InChI InChI=1S/C10H12N6O/c11-8-7-5-12-10(15-9(7)14-6-13-8)16-1-3-17-4-2-16/h5-6H,1-4H2,(H2,11,12,13,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.68E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333210
(5-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | CHEMB...)Show InChI InChI=1S/C12H9N3/c1-4-13-5-2-9(1)11-7-10-3-6-14-12(10)15-8-11/h1-8H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4.08E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333213
(5-(pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2...)Show InChI InChI=1S/C10H8N6/c11-9-14-10-13-8(3-6-16(10)15-9)7-1-4-12-5-2-7/h1-6H,(H2,11,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333218
(7-morpholinopyrimido[4,5-d]pyrimidin-4-amine | CHE...)Show InChI InChI=1S/C10H12N6O/c11-8-7-5-12-10(15-9(7)14-6-13-8)16-1-3-17-4-2-16/h5-6H,1-4H2,(H2,11,12,13,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.32E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333211
(2-(pyridin-4-yl)thiazolo[5,4-d]pyrimidin-7-amine |...)Show InChI InChI=1S/C10H7N5S/c11-8-7-10(14-5-13-8)16-9(15-7)6-1-3-12-4-2-6/h1-5H,(H2,11,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.35E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333223
(6-amino-2'-methyl-3,4'-bipyridine-5-carboxamide | ...)Show InChI InChI=1S/C12H12N4O/c1-7-4-8(2-3-15-7)9-5-10(12(14)17)11(13)16-6-9/h2-6H,1H3,(H2,13,16)(H2,14,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333213
(5-(pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2...)Show InChI InChI=1S/C10H8N6/c11-9-14-10-13-8(3-6-16(10)15-9)7-1-4-12-5-2-7/h1-6H,(H2,11,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5.54E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333225
(1-methyl-1H-pyrrolo[2,3-c]pyridin-5-amine | CHEMBL...)Show InChI InChI=1S/C8H9N3/c1-11-3-2-6-4-8(9)10-5-7(6)11/h2-5H,1H3,(H2,9,10) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 5.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333210
(5-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | CHEMB...)Show InChI InChI=1S/C12H9N3/c1-4-13-5-2-9(1)11-7-10-3-6-14-12(10)15-8-11/h1-8H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 5.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333213
(5-(pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2...)Show InChI InChI=1S/C10H8N6/c11-9-14-10-13-8(3-6-16(10)15-9)7-1-4-12-5-2-7/h1-6H,(H2,11,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50024966
(6-Oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile...)Show InChI InChI=1S/C11H7N3O/c12-6-9-5-10(7-14-11(9)15)8-1-3-13-4-2-8/h1-5,7H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 6.57E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333210
(5-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine | CHEMB...)Show InChI InChI=1S/C12H9N3/c1-4-13-5-2-9(1)11-7-10-3-6-14-12(10)15-8-11/h1-8H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 7.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333220
(5-(pyridin-4-yl)benzo[d]thiazol-2-amine | CHEMBL16...)Show InChI InChI=1S/C12H9N3S/c13-12-15-10-7-9(1-2-11(10)16-12)8-3-5-14-6-4-8/h1-7H,(H2,13,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50333214
(2-(pyridin-4-yl)benzo[d]oxazol-5-amine | CHEMBL164...)Show InChI InChI=1S/C12H9N3O/c13-9-1-2-11-10(7-9)15-12(16-11)8-3-5-14-6-4-8/h1-7H,13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110beta catalytic subunit by AlphaScreen competition assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333212
(2-(pyridin-4-yl)benzo[d]oxazol-5-ol | CHEMBL164509...)Show InChI InChI=1S/C12H8N2O2/c15-9-1-2-11-10(7-9)14-12(16-11)8-3-5-13-6-4-8/h1-7,15H | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333218
(7-morpholinopyrimido[4,5-d]pyrimidin-4-amine | CHE...)Show InChI InChI=1S/C10H12N6O/c11-8-7-5-12-10(15-9(7)14-6-13-8)16-1-3-17-4-2-16/h5-6H,1-4H2,(H2,11,12,13,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50024966
(6-Oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile...)Show InChI InChI=1S/C11H7N3O/c12-6-9-5-10(7-14-11(9)15)8-1-3-13-4-2-8/h1-5,7H,(H,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333217
(4-methyl-2-morpholinothiazole-5-carboxylic acid | ...)Show InChI InChI=1S/C9H12N2O3S/c1-6-7(8(12)13)15-9(10-6)11-2-4-14-5-3-11/h2-5H2,1H3,(H,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333214
(2-(pyridin-4-yl)benzo[d]oxazol-5-amine | CHEMBL164...)Show InChI InChI=1S/C12H9N3O/c13-9-1-2-11-10(7-9)15-12(16-11)8-3-5-14-6-4-8/h1-7H,13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50333213
(5-(pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2...)Show InChI InChI=1S/C10H8N6/c11-9-14-10-13-8(3-6-16(10)15-9)7-1-4-12-5-2-7/h1-6H,(H2,11,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human p110alpha PI3K fragment by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333214
(2-(pyridin-4-yl)benzo[d]oxazol-5-amine | CHEMBL164...)Show InChI InChI=1S/C12H9N3O/c13-9-1-2-11-10(7-9)15-12(16-11)8-3-5-14-6-4-8/h1-7H,13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333214
(2-(pyridin-4-yl)benzo[d]oxazol-5-amine | CHEMBL164...)Show InChI InChI=1S/C12H9N3O/c13-9-1-2-11-10(7-9)15-12(16-11)8-3-5-14-6-4-8/h1-7H,13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333216
(4-(1H-pyrazolo[3,4-b]pyridin-4-yl)morpholine | CHE...)Show InChI InChI=1S/C10H12N4O/c1-2-11-10-8(7-12-13-10)9(1)14-3-5-15-6-4-14/h1-2,7H,3-6H2,(H,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50333212
(2-(pyridin-4-yl)benzo[d]oxazol-5-ol | CHEMBL164509...)Show InChI InChI=1S/C12H8N2O2/c15-9-1-2-11-10(7-9)14-12(16-11)8-3-5-13-6-4-8/h1-7,15H | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110delta catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333212
(2-(pyridin-4-yl)benzo[d]oxazol-5-ol | CHEMBL164509...)Show InChI InChI=1S/C12H8N2O2/c15-9-1-2-11-10(7-9)14-12(16-11)8-3-5-13-6-4-8/h1-7,15H | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50333215
(7-morpholinoquinazolin-4(3H)-one | CHEMBL1645100)Show InChI InChI=1S/C12H13N3O2/c16-12-10-2-1-9(7-11(10)13-8-14-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2,(H,13,14,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >8.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D M£lndal
Curated by ChEMBL
| Assay Description Inhibition of human PI3K p110gamma catalytic subunit by AlphaScreen assay |
Bioorg Med Chem Lett 21: 829-35 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.087 BindingDB Entry DOI: 10.7270/Q298878P |
More data for this Ligand-Target Pair | |